WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997019931) 2-(SUBSTITUTED SULFANYL)-3,5-DIHYDRO-IMIDAZOL-4-ONE DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/019931    International Application No.:    PCT/US1996/019108
Publication Date: 05.06.1997 International Filing Date: 25.11.1996
Chapter 2 Demand Filed:    18.06.1997    
IPC:
A61K 31/4166 (2006.01)
Applicants: AMERICAN HOME PRODUCTS CORPORATION [US/US]; Five Giralda Farms, Madison, NJ 07940-0874 (US)
Inventors: ELOKDAH, Hassan, Mahmoud; (US).
SULKOWSKI, Theodore, Sylvester; (US).
STRIKE, Donald, Peter; (US)
Agent: ALICE, Ronald, W.; American Home Products Corporation, Patent Law Dept. - 2B, One Campus Drive, Parsippany, NJ 07054 (US).
WILEMAN, D., F.; Wyeth Laboratories, Huntercombe Lane South, Taplow, Maidenhead, Berkshire SL6 OPH (GB)
Priority Data:
60/007,653 28.11.1995 US
08/563,841 28.11.1995 US
Title (EN) 2-(SUBSTITUTED SULFANYL)-3,5-DIHYDRO-IMIDAZOL-4-ONE DERIVATIVES
(FR) DERIVES DE 2-(SUBSTITUTION SULFANYLE)-3,5-DIHYDROIMIDAZOL-4-ONE
Abstract: front page image
(EN)The compounds of formula (I): wherein R is phenyl or phenyl optionally substituted with one or more groups selected from halogen, alkyl, perfluoroalkyl, alkoxy, perfluoroalkoxy, hydroxy, alkanoyloxy, aroyloxy or arylalkanoyloxy; R?3¿ is alkyl, aryl or arylalkyl; or a pharmaceutically acceptable salt thereof, are use for increasing HDL blood levels.
(FR)L'invention concerne un composé de la formule (I). Dans cette formule, R est un phényle éventuellement substitué avec un ou plusieurs groupes choisis parmi: halogène, alkyle, perfluoroalkyle, alcoxy, perfluoroalcoxy, hydroxy, alcanoyloxy, aroyloxy ou arylalcanoyloxy; R?3¿ est un alkyle, aryle ou aralkyle. L'invention concerne également les sels de ces composés acceptables sur le plan pharmaceutique. Ces dérivés et leurs sels sont utiles pour augmenter les niveaux de HDL dans le sang.
Designated States: AL, AU, BB, BG, BR, CA, CN, CZ, EE, GE, HU, IL, IS, JP, KP, KR, LK, LR, LT, MG, MK, MN, MX, NO, NZ, PL, RO, SG, SI, SK, TR, TT, UA, UZ, VN.
African Regional Intellectual Property Organization (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)